marijuana stocks news

The MaryJane Group, Inc. (MJMJ)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Oct 31, 2014 Jul 31, 2014 Apr 30, 2014 Jan 31, 2014
Total Revenue 164   113   16   –  
Cost of Revenue 94 87 6
Gross Profit 70   26   10   –  
Operating Expenses
Research Development
Selling General and Administrative 1,094 489 213 13
Non Recurring
Others 1 1 9
Total Operating Expenses
Operating Income or Loss (1,025) (464) (212) (13)
Income from Continuing Operations
Total Other Income/Expenses Net (7) (50)
Earnings Before Interest And Taxes (1,032) (513) (212) (13)
Interest Expense 90 64 1
Income Before Tax (1,122) (578) (213) (13)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,122) (578) (213) (13)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,122) (578) (213) (13)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,122) (578) (213) (13)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Fire & Flower Holdings Corp. (FFLWF) Appoints Nadia Vattovaz to Chief Operating Officer and Announces Judy Adam as New Chief Financial Officer

Fire & Flower Appoints Nadia Vattovaz to Chief Operating Officer and Announces…

$BLPG #Wins Licenses to Open Operations in Nevada

Blue Line Protection Group Wins Licenses to Open Operations in Nevada DENVER,…

Enertopia Corporation (ENRT) Provides Company Update

Enertopia Provides Company Update    Enertopia Corporation (OTCQB: ENRT) on the OTC (the “Company” or…

InMed Pharmaceuticals Inc. (IMLFF) Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755

InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755…